HealthIs Alzheimer’s drug donanemab really a 'turning point' for treatment? The experimental drug donanemab slows the progression of Alzheimer's disease compared with a placebo, but the effect may not be large enough to be noticed by people with the condition or their families News
HealthDrugs that mutate viruses to kill them could make them more dangerous Several antiviral drugs kill viruses by inducing lots of mutations, but a computer model suggests this could have unpredictable consequences News